The total value of the catalog peptides market is on the rise, and this trend will continue to grow in the years to come as well. Expansion of technologies for lucrative making of catalog peptides, growing number of research activities for addressing unmet medical requirements in numerous therapeutic areas, rising burden of chronic ailments, and snowballing investments and funding for protein-based research are driving the industry. On the basis of type, the cyclic category led the industry with regards to revenue. This has a lot to do with the fact that cyclic peptides have different biological activities, for example immunosuppressive, antibacterial, and anti-tumor activities. Talking of the end user, the catalog peptides market has pharma and biotech companies, CMOs and CROs, and academic and research organizations.
Amongst these, pharma and biotech companies make the most use of catalog peptides. This can be credited to the fact that drug manufacturers are more and more evaluating the usage of peptides as therapeutics, since peptides provide greater chemical diversity than any class of biological molecules, and have stability and high target affinity. Growing number of research activities associated with recombinant proteins and introduction of products are the latest trends in the industry. Recombinant DNA tech is considered the most efficient molecular biology methods in the life sciences sector for producing biopharmaceuticals. Recombinant protein-based expression can be put to use for the expansion of peptide-based biopharmaceuticals. The capability of the tech to produce a plentiful volume of desired and purified recombinant protein, may bring about its potential application in industrial procedures and in the analysis and treatment of diseases. So, growing research actions on peptide synthesis and growing investments for large production of recombinant proteins, used as biotherapeutics, are boosting the industry growth. On the basis of application, the industries have various categories into academic research, commercial, and therapeutics applications. Catalog peptides, which are put to use for commercial applications had more than half of the share in the past, in the market. This is because catalog peptides are used in various commercial applications in beauty and cosmetics other industries. North America was the leader of the pack, as far as the region is concerned. The primary reason for this is the presence of major players in the region. Though, APAC will have the fastest growth in the industry, mainly because of the increasing prevalence of chronic ailments in the region. It is because of the growing burden of chronic diseases all over the world, the demand for catalog peptides is on the rise. And, this trend will continue in the years to come as well.
SOURCE: P&S Intelligence
%20Pipe%20Market_29Apr21%20(2).jpg)
0 Comments